Zdrowie i gospodarka · 29/10/2015

FDA Establishes Public Docket to Gather Input on Using Technologies in Clinical Investigations

The Food and Drug Administration (FDA) is launching a public forum to gather feedback from various stakeholders on the use of cutting-edge technologies and innovative methods in conducting clinical trials of investigational drugs, with a focus on improving efficiency and addressing potential barriers to adoption.